Evaluation of the Hypoallergenicity of a New Formula Based on Hydrolyzed Rice Proteins
Evaluation of the Hypoallergenicity of a New Formula Based on Hydrolyzed Rice Proteins (TRHF 2017) in Children With Confirmed Immunoglobulin E (IgE) or Non-immunoglobulin E-mediated Cow's Milk Allergy (CMA)
Sponsor: Statitec
A NA clinical study on Cow Milk Allergy, this trial is completed. The trial is conducted by Statitec and has accumulated 6 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Dec 2020 — Jan 2021 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jul 2020 — Dec 2020 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 1 earlier version
-
Jul 2018 — Jul 2020 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Statitec
- United Pharmaceuticals
For direct contact, visit the study record on ClinicalTrials.gov .